Point72 Asia Singapore Pte. Ltd. Takes $143,000 Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 7,547 shares of the medical instruments supplier’s stock, valued at approximately $143,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Point72 Asset Management L.P. bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at about $179,000. Quantinno Capital Management LP boosted its holdings in shares of DENTSPLY SIRONA by 58.7% during the fourth quarter. Quantinno Capital Management LP now owns 185,399 shares of the medical instruments supplier’s stock worth $3,519,000 after purchasing an additional 68,591 shares during the period. Man Group plc boosted its holdings in shares of DENTSPLY SIRONA by 375.1% during the fourth quarter. Man Group plc now owns 177,962 shares of the medical instruments supplier’s stock worth $3,378,000 after purchasing an additional 140,503 shares during the period. Nomura Holdings Inc. purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $501,000. Finally, Mork Capital Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $1,002,000. 95.70% of the stock is owned by institutional investors.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on XRAY. Mizuho dropped their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a report on Thursday, March 13th. Barrington Research increased their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Monday, May 12th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a report on Friday, May 9th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $20.36.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $16.70 on Friday. The stock’s 50 day simple moving average is $14.41 and its two-hundred day simple moving average is $17.38. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market cap of $3.33 billion, a price-to-earnings ratio of -8.07, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $28.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $879.00 million for the quarter, compared to analysts’ expectations of $854.75 million. During the same period in the previous year, the firm posted $0.42 EPS. The business’s revenue was down 7.8% on a year-over-year basis. As a group, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 3.83%. DENTSPLY SIRONA’s payout ratio is -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.